Geoffrey S. Martha's most recent trade in NextEra Energy Inc was a trade of 2,700 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NextEra Energy | Geoffrey S. Martha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,700 | 3,870 (0%) | 0% | 0 | Common Stock | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 34,741 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. | 27 Jan 2025 | 34,741 | 216,954 (0%) | 0% | 74.8 | 2,600,016 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.46 per share. | 27 Jan 2025 | 30,184 | 186,770 (0%) | 0% | 92.5 | 2,790,813 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. | 16 Dec 2024 | 4,417 | 181,326 (0%) | 0% | 82.5 | 364,314 | Ordinary Shares |
| NextEra Energy | Geoffrey S. Martha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 1,170 | 1,170 (0%) | 0% | 0 | Common Stock | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 18,966 | 203,086 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 18,966 | 0 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 9,523 | 184,914 (0%) | 0% | 81.5 | 776,220 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 8,649 | 194,437 (0%) | 0% | 81.5 | 704,980 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 295,680 | 295,680 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 100,000 | 100,000 | - | - | Performance Share Unit | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 40,000 | 184,120 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 17,519 | 1,594 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. | 07 Jun 2024 | 17,519 | 160,867 (0%) | 0% | 62.8 | 1,099,492 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 83.76 per share. | 07 Jun 2024 | 17,519 | 144,942 (0%) | 0% | 83.8 | 1,467,391 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 83.82 per share. | 07 Jun 2024 | 1,594 | 143,348 (0%) | 0% | 83.8 | 133,609 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 1,594 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. | 07 Jun 2024 | 1,594 | 162,461 (0%) | 0% | 62.8 | 100,039 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 18,165 | 0 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 18,165 | 159,109 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. | 03 Aug 2023 | 17,965 | 141,144 (0%) | 0% | 84.5 | 1,517,863 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 240,691 | 481,382 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 85,461 | 85,461 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 34,185 | 139,097 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 224,996 | 224,996 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 71,176 | 71,176 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 28,471 | 102,497 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Jul 2022 | 23,410 | 74,026 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Sale of securities on an exchange or to another person at price $ 132.67 per share. | 25 Aug 2021 | 10,100 | 95,836 (0%) | 0% | 132.7 | 1,339,967 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 10,100 | 17,519 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. | 25 Aug 2021 | 10,100 | 105,936 (0%) | 0% | 62.8 | 633,876 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. | 25 Aug 2021 | 1,481 | 97,317 (0%) | 0% | 55.3 | 81,929 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Sale of securities on an exchange or to another person at price $ 132.67 per share. | 25 Aug 2021 | 1,481 | 95,836 (0%) | 0% | 132.7 | 196,484 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 1,481 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 162,731 | 162,731 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 47,616 | 47,616 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 19,047 | 95,836 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 02 Aug 2021 | 5,450 | 76,789 (0%) | 0% | 131.3 | 715,640 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. | 28 Jun 2021 | 11,500 | 93,448 (0%) | 0% | 55.3 | 636,180 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 11,500 | 1,481 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Sale of securities on an exchange or to another person at price $ 125.29 per share. | 28 Jun 2021 | 11,500 | 81,948 (0%) | 0% | 125.3 | 1,440,835 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Sale of securities on an exchange or to another person at price $ 118.83 per share. | 05 Apr 2021 | 9,308 | 81,938 (0%) | 0% | 118.8 | 1,106,070 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. | 05 Apr 2021 | 9,308 | 91,246 (0%) | 0% | 55.3 | 514,919 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 9,308 | 11,173 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 2,404 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.60 per share. | 05 Apr 2021 | 2,404 | 84,342 (0%) | 0% | 41.6 | 100,006 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Sale of securities on an exchange or to another person at price $ 118.83 per share. | 05 Apr 2021 | 2,404 | 81,938 (0%) | 0% | 118.8 | 285,667 | Ordinary Shares |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 51,758 | 51,758 | - | - | Performance Share Units | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 212,529 | 212,529 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 71,158 | 71,158 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 23,118 | 81,094 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Geoffrey S. Martha | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.48 per share. | 31 Jul 2020 | 4,252 | 57,976 (0%) | 0% | 96.5 | 410,233 | Ordinary Shares |